TickerTain
$SPCX····$NVDA····$MSFT····$GOOGL····$ANTHROPIC·$TSLA····$CRWV····$NBIS····$HIMS····$TSM····$ASML····$FIGURE·$LYFT····$UBER····$SNOW····$META····$ELEVENLABS·$CURSOR·$COGNITION·$OPENAI·$AAPL····$RKLB····$XAI·$AMZN····$AMD····$000660.KS····$INTC····
← newsroom
AI Geopolitics & Export Controls · China aggressively stealing US biotech IP via distillation and patent system, FDA slowness exacerbates disadvantage
now playing · AI Geopolitics & Export Controls
Defense Techtailwindscore 9/10joe lonsdale
Pentagon procurement shifting to startups as Anduril, Saronic demonstrate 10x better solutions
A cultural shift in the Pentagon over the last 5-6 years is opening defense procurement to startups like Anduril and Saronic, which deliver dramatically better and cheaper solutions than tr…
Memory & Storagetailwindscore 8/10unknown
AI demand transforms memory from cyclical to structural growth via multi-year contracts
Memory chipmakers like SK Hynix and Micron are signing multi-year supply agreements with desperate AI customers, fundamentally reducing the cyclicality that has historically defined the mem…
Space Economytailwindscore 8/10brendan carr
FCC accelerates space economy approvals, targeting orbital data centers and direct-to-device leadership
The FCC is moving to an assembly-line approval model for space applications, cutting backlog by half, and aims to establish two to three US direct-to-device providers to lead globally, bene…
AI Geopolitics & Export Controlsheadwindscore 8/10joe lonsdale
China aggressively stealing US biotech IP via distillation and patent system, FDA slowness exacerbates disadvantage
China has captured over one-third of global therapeutics development by systematically stealing US IP through distillation, patent exploitation, and talent transfer, while the FDA's 700-day…
AI Hardware & Chip Architecturemixedscore 7/10unknown
Nvidia's AI chip dominance faces long-term pressure from custom silicon and memory innovation
While Nvidia dominates AI chips today, competitors like Google and startups are developing architectures that use different memory types or less memory, creating long-term competitive risk.
AI Drug Discoverymixedscore 7/10joe lonsdale
AI driving biotech breakthroughs in bone marrow grafts and antibodies, but China IP theft threatens investment returns
AI is enabling major biotech advances like bone marrow graft alternatives and antibody platforms, but the inability to protect IP from Chinese theft undermines the profitability of US biote…
Tech Regulation & Antitrustheadwindscore 7/10joe lonsdale
Lonsdale calls FDA an unaccountable 'mafia' slowing biotech, advocates multiple competing regulatory bodies
The FDA's unchecked power and 700-day approval timelines are a major bottleneck for US biotech competitiveness; Lonsdale proposes multiple competing regulatory bodies to accelerate drug dev…
Venture Capitaltailwindscore 7/10joe lonsdale
8VC's $1.5B fund reflects accelerated venture pace, holding defense and AI winners long-term
Venture capital is seeing unprecedented markup velocity with companies doubling revenue quarterly; 8VC plans to hold its best defense and AI positions indefinitely rather than exit.
Tech Regulation & Antitrustheadwindscore 6/10mark gurman
Apple's trade secret lawsuit against OpenAI chills AI talent mobility
Apple's aggressive litigation against OpenAI for recruiting former employees will deter talent flows between major AI labs, potentially slowing cross-pollination.